The role of hydrosalpinx in recurrent miscarriage

  • Research type

    Research Study

  • Full title

    The role of hydrosalpinx in recurrent miscarriage

  • IRAS ID

    232650

  • Contact name

    J Ghosh

  • Contact email

    jayasish.ghosh@nhs.net

  • Sponsor organisation

    University of Birmingham

  • Clinicaltrials.gov Identifier

    RG_17-150, University of Birmingham Research Governance Ref Number; ERN_17-1086, University of Birmingham Research Support Group Ref Number

  • Duration of Study in the UK

    2 years, 5 months, 31 days

  • Research summary

    Attenders at a recurrent miscarriage clinic will be screened for hydrosalpinges. Miscarriage is defined as spontaneous pregnancy loss before the fetus reaches viability. Hydrosalpinges are an abnormal dilation of a fallopian tube classically caused by sexually transmitted infections such as Chlamydia trachomatis, pelvic inflammatory disease, previous abdominal surgery causing scar tissue or endometriosis which causes a distal occlusion of the tube. They will be screened by performing a hysterosalpingo-contrast-sonogram (HyCoSy). A HyCoSy is an ultrasound scan performed in the outpatient setting. A routine transvaginal ultrasound scan is performed and then a contrast media is introduced into the uterus via the cervix and the flow of the contrast through the fallopian tubes is tracked in real time using ultrasound. This will enable me to establish the prevalence of hydrosalpinges in the recurrent miscarriage population. I will then follow up both those who screen positive and those who screen negative for hydrosalpinges for 12 months in terms of their subsequent pregnancy outcomes. I will compare these 2 cohorts to each other to establish the prognosis of miscarriage in women with concurrent hydrosalpinges. If women are found to have hydrosalpinges they and their routine healthcare provider will be informed and treated appropriately. This may include surgical treatment. The pregnancy outcomes of those who were treated with surgery will then be compared to those who did not. This is to see if surgery improves the prognosis of women with recurrent miscarriage and concurrent hydrosalpinges and what type of surgery in particular was better. If the surgery does show an improved prognosis, all those women who initially declined intervention will be re-offered surgery by their routine healthcare provider.

  • REC name

    West Midlands - Edgbaston Research Ethics Committee

  • REC reference

    17/WM/0444

  • Date of REC Opinion

    16 Jan 2018

  • REC opinion

    Further Information Favourable Opinion